Financial reports
ARS
2023 FY
Annual report to shareholders
26 Mar 24
10-K
2023 FY
Annual report
21 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
ARS
2022 FY
Annual report to shareholders
23 Jun 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K/A
2022 FY
Annual report (amended)
28 Mar 23
10-K
2022 FY
Annual report
21 Feb 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
Current reports
8-K
Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results
21 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
12 Jan 24
8-K
Dermata Announces Exercise of Warrants for $2.26 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
17 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
15 Nov 23
8-K
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
9 Nov 23
8-K
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter
10 Aug 23
8-K
Changes in Registrant's Certifying Accountant
3 Aug 23
8-K
Dermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules
24 May 23
8-K
Dermata Therapeutics Provides Corporate Update and Reports First Quarter
11 May 23
8-K
Other Events
28 Mar 23
Registration and prospectus
424B3
Prospectus supplement
15 Dec 23
S-3
Shelf registration
7 Dec 23
S-8
Registration of securities for employees
14 Sep 23
424B4
Prospectus supplement with pricing info
27 Jul 23
S-1
IPO registration
7 Jul 23
D
Indefinite amount in options / securities to be acquired, 2 investors
12 Jun 23
424B5
Prospectus supplement for primary offering
25 May 23
424B3
Prospectus supplement
20 Mar 23
424B4
Prospectus supplement with pricing info
20 Mar 23
S-1/A
IPO registration (amended)
16 Mar 23
Proxies
DEFA14A
Additional proxy soliciting materials
26 Mar 24
DEF 14A
Definitive proxy
26 Mar 24
PRE 14A
Preliminary proxy
1 Mar 24
DEF 14A
Definitive proxy
8 Dec 23
PRE 14A
Preliminary proxy
29 Nov 23
DEFA14A
Additional proxy soliciting materials
12 Jul 23
DEFA14A
Additional proxy soliciting materials
23 Jun 23
DEF 14A
Definitive proxy
23 Jun 23
DEF 14A
Definitive proxy
13 Jan 23
PRE 14A
Preliminary proxy
3 Jan 23
Other
EFFECT
Notice of effectiveness
18 Dec 23
CORRESP
Correspondence with SEC
13 Dec 23
UPLOAD
Letter from SEC
13 Dec 23
EFFECT
Notice of effectiveness
28 Jul 23
CORRESP
Correspondence with SEC
25 Jul 23
UPLOAD
Letter from SEC
14 Jul 23
EFFECT
Notice of effectiveness
17 Mar 23
CORRESP
Correspondence with SEC
16 Mar 23
CORRESP
Correspondence with SEC
16 Mar 23
CORRESP
Correspondence with SEC
14 Mar 23